Sanamedi / Portfolio

PORTFOLIO

Sanamedi has a track record of supporting the development of a wide range of products,
including not only Class IV products, but also program medical devices and healthcare services.

※This website contains information about products that may not be available in all countries. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site.Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

IN-HOUSE DEVELOPMENT

  • AVNeo (Aortic Valve Neo-cuspidization) Sizer System
    – In-house development of an innovative device required for a cutting edge cardiac surgical procedure (AVNeo) developed in Japan.
    – Product developed in-house (including license from a university)
    – Distribution contracts signed with partners in 50 countries, currently expanding distribution markets (as of Feb 2023)
    – See owntissuevalve.org,AVNeo.net ,LinkedIn, and facebook for more on this procedure.
  • 3D back scanner® for scoliosis screening
    –Space Vision, Inc. developed with Keio University.
    –Launched by Nippon Zoki Pharmaceutical Co., Ltd.(press release
    – LED light source and to capture an image of the patient’s back in 3D and convert it to a mirror image
    –Supported by the JMA program, the development and commercialization of medical devices continues to progress (Japan Medical Association)
    –Launched in Japan in February 2020 / globally unapproved
    –Class I medical device (Japanese registration number 13B1X10274000004)
  • First Made in Japan Abdominal Aortic Aneurysm Stent Graft
    – A stent graft entirely manufactured in Japan, highly competitive and features the concentration of Japanese technologies
    – Aiming for unprecedented thin products under development
    – Joint development with world renowned vascular surgeon, Professor Takao Ohki, and and key Japanese medical device manufacturers, MANI, Inc., and SB-Kawasumi Laboratories, Inc.
    – In development / globally unapproved
  • “True Puncture®”, a Needle Guide Device for Ultrasound-guided Puncture
    Ultrasound guided puncture needle guide “True Puncture®”
    – A device that enables practitioners to confirm appropriate line of sight, needle positioning and angle by placing a mirror on the puncture adapter
    – An innovative guide system that enables a straight insertion of needles even for punctures made directly from the side
    – Can be applied in cardiovascular, cardiac surgery, vascular surgery, and tumor-related surgeries (gastrointestinal surgery, respiratory surgery, breast surgery), orthopedic surgery, nephrology, etc.
    – Class I medical device (Japanese registration number 8876083023)
  • “BiologicMate®” Prediction System for Treatment Effect of Biologics for Rheumatoid Arthritis
    – Measures the level of ADAMTS5 mRNA expression in the blood prior to administration of biological drugs
    –Not only does it have the merit of protecting patients from the side effects of ineffective drugs, it will also contribute to reducing medical expenses and may become effective precision medicine
    – In development / globally unapproved
    “Talin Test” High-Sensitivity Diagnostic Kit for Rheumatoid Arthritis
    – A new method for diagnosing rheumatoid arthritis based on the fact that talin, a protein that is expressed in the regions of cell-cell contact in lymphocytes, is expressed in the short form (short talin) in the blood of patients with rheumatoid arthritis
    – May have superior sensitivity and specificity compared with conventional methods for diagnosing rheumatoid arthritis
    – Distribution began in the U.S. from September 2017 for research use only (RUO)
    – In development / globally unapproved
  • AI-assisted automatic sperm sorting device
    – In development by Dr. Kazuhiro Kawamura, International University of Health and Welfare, Dr. Masashi Ikeuchi, Tokyo Medical and Dental University, and Sanamedi
    – Sanamedi will develop the device to order to aid in the embryologists’ sperm selection and improve workflow
    – In development / globally unapproved

INVESTMENT

At Sanamedi, which develops medical product incubation businesses,
we also support fund raising for startup companies that we support. After the investment, by supporting various commercialization aspects,
of the twelve (12) companies we have invested in so far, five (5) have successfully exited.